# Fulcrum Therapeutics

Type: Company (FULC)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/fulcrum-therapeutics
Canonical HTML page: https://getfinancebrief.com/entity/fulcrum-therapeutics

## Recent coverage (1 stories)

### Short Interest Surges for Fulcrum and MillerKnoll Amid Market Shifts
2026-03-18 03:09:17 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Recent short interest updates for Fulcrum Therapeutics and MillerKnoll signal growing investor caution as both companies navigate critical operational and macroeconomic challenges. While Fulcrum faces clinical-stage volatility following in-line earnings, MillerKnoll contends with a Hold consensus and broader pressure on the office furniture sector.
Full story: https://getfinancebrief.com/story/fulcrum-millerknoll-short-interest-update-march-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.